<DOC>
	<DOCNO>NCT00401167</DOCNO>
	<brief_summary>Alzheimer 's disease ( AD ) common form dementia characterize cognitive behavioural symptom ( `` Behavioural Psychological Symptoms Dementia '' ; BPSD ) . To date , modestly effective treatment BPSD , treatment associate increase risk mortality elderly dementia patient . We plan study whether treatment medication memantine improve BPSD severe AD patient . Thirty-two AD patient significant BPSD , include agitation aggression , treat three month memantine . Assessments behavioural symptom global clinical outcome complete one , two three month treatment .</brief_summary>
	<brief_title>Memantine Agitation Aggression Severe Alzheimer 's Disease</brief_title>
	<detailed_description>BPSD institutionalize patient severe AD serious public health problem . The effectiveness current pharmacological management BPSD atypical antipsychotic modest best , serious safety concern include increase cerebrovascular adverse event increase mortality . Preliminary data memantine suggest medication may helpful treat BPSD severe subgroup Alzheimer 's disease patient population . It reason propose open-label prospective study memantine institutionalize patient severe Alzheimer 's disease significant BPSD . The major objective study examine effectiveness memantine behaviour focus agitation aggression . The secondary objective determine effect memantine nursing burden prescription medication use . The study would expand clinical experience memantine provide information professional caregiver burden prescription medication use institutionalize , severely impaired frailer population . This information could use design randomized placebo control confirmatory trial . The effectiveness memantine agitation aggression patient moderate severe Alzheimer 's disease assess 3-month , open-label study involve 32 patient reside long-term care facility .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Signed informed consent obtain legally acceptable representative Male female &gt; 65 year age , reside longterm care Diagnosis Statistical Manual Mental Disorders ( DSMIVTR ) diagnosis Dementia Alzheimer 's type ( code 290.1 ) Mini Mental State Examination total score â‰¤ 15 Neuropsychiatric InventoryNursing Home Version total score &gt; 10 , score &gt; 1 agitation/aggression subscale A current order prescription medication behavioral psychological symptom dementia ( e.g . benzodiazepine , antipsychotic , trazodone ) , least 1 dose use prior 3 month Patients current order regularly administer psychotropic ( example , selective serotonin reuptake inhibitor , serotoninnorepinephrine reuptake inhibitor , trazodone , atypical antipsychotic , typical antipsychotic cholinesterase inhibitor ) must stable dose 3 month prior entry Current evidence uncontrolled medical illness would interfere subject 's participation study Dementia due etiology Alzheimer 's Disease Subjects experience significant difficulty ingest oral medication</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>behavioral psychological symptom dementia</keyword>
	<keyword>severe Alzheimer 's disease</keyword>
	<keyword>memantine</keyword>
	<keyword>agitation</keyword>
	<keyword>aggression</keyword>
</DOC>